MED-FINE CAPITAL
Founded in 2014 at the China’s financial hub-Shanghai, Mefund Capital is a young investment fund. Mefund owns holdings of Shanghai Mefund Capital and Mefund Capital Management (Beijing), and is a shareholder of Noajin Asset Management.
MED-FINE CAPITAL
Industry:
Finance Financial Services Venture Capital
Founded:
2014-01-01
Status:
Active
Contact:
+86 21 63269680
Email Addresses:
[email protected]
Technology used in webpage:
Xinnet DNS
Similar Organizations
Icon Ventures
Icon Ventures is a specialty venture capital firm focused on leading Series B or C financings.
Leton Capital
Leton Capital is a venture capital firm focuses on the internet industry.
Prosperico Ventures
Prosperico Ventures is a venture capital firm focused on healthcare and the high-tech industry.
Ruyi Capital
Ruyi Capital is a venture capital firm focused on entertainment, education and internet.
SAIC Capital
SAIC Capital is a venture capital firm specializing in direct and fund of funds investments.
Section 32
Section 32 is a venture capital fund that invests at the cutting edge of technology, healthcare, and life sciences.
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-09 | Degron Therapeutics | Med-Fine Capital investment in Series A - Degron Therapeutics | 22 M USD |
| 2022-02-28 | CorrGene | Med-Fine Capital investment in Seed Round - CorrGene | 15.7 M USD |
| 2022-01-13 | Westlake Omics | Med-Fine Capital investment in Seed Round - Westlake Omics | N/A |
| 2021-12-21 | AccuPulse | Med-Fine Capital investment in Seed Round - AccuPulse | 8 M USD |
| 2021-11-24 | Allorion Therapeutics | Med-Fine Capital investment in Series A - Allorion Therapeutics | 40 M USD |
| 2021-10-08 | Med-Vision | Med-Fine Capital investment in Series A - Med-Vision | N/A |
| 2021-10-08 | Epintek | Med-Fine Capital investment in Series C - Epintek | N/A |
| 2021-09-28 | Immunophage Biotech | Med-Fine Capital investment in Series A - Immunophage Biotech | N/A |
| 2021-08-27 | LYNK Pharmaceuticals | Med-Fine Capital investment in Series B - LYNK Pharmaceuticals | 50 M USD |
| 2021-05-09 | Alebund Pharmaceuticals | Med-Fine Capital investment in Series B - Alebund Pharmaceuticals | 60 M USD |